R&D Discovery Boston751235402
08:00 AM EST

Drug Discovery Biology
Strategy Meeting East Coast USA 2023

Understanding Complex Structure, Properties and Dynamics of Biological Phenomena in Drug Discovery: Emerging Tools and Next Generation Drug Target Characterization, Validation and Safety Profiling

What makes our strategy meetings unique?


Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.


Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.


Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.


Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.


Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.


Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Meet Our Past Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Drug Discovery Biology strategy meeting.

Henry Lu

VP & Head of Discovery Biology WuXi AppTec

Letian Kuai, Ph.D

Executive Director, DEL Technology and Strategy Chief Scientific Officer, Crelux WuXi AppTec

Andreas Schoops

Head of Medicinal Chemistry WuXi AppTec

Dominic Hussey

Territorial Head-EMEA Sales Bit.Bio

Frank Kruse

Vice President of Marketing and Business Development Sekisui Xenotech

Terri Almos

Executive Director, Emerging Science & Innovation Inflammation & Immunology Pfizer

Karim Azer

VP, Head of Platform & Discovery Axcella

Carla Bauer

Associate Director, Strategic Transactions, Business Development & Licensing Novartis

Govinda Bhisetti

Vice President and Head of Computational Chemistry Cellarity

Matthew Calabrese

Senior Director and Head of Structural and Molecular Sciences Pfizer

Prasoon Chaturvedi

Vice President, Head of DMPK C4 Therapeutics, Inc.

Brent Cezairliyan

Vice President, Biology Octagon Therapeutics

Rob Foti

Senior Director, Preclinical Development (ADME & Discovery Toxicology) MERCK

Vibha Jawa

Executive Director, Nonclinical Disposition and Bioanalysis Bristol Myers Squibb

Matthew Lech

Principal Research Scientist Pfizer

Jing Li

Executive Director Biology PTC Therapeutics, Inc.

Diane Joseph McCarthy

Executive Director, Bioengineering Technology & Entrepreneurship Center Boston University

Li Peng

Chief Scientific Officer Palleon Pharmaceuticals

Nisha Perez

Senior Director, Head of DMPK ROME Therapeutics

John Reilly

Chief Scientific Officer Nereid Therapeutics

Cara Williams

Vice President Head of Preclinical Biology: Inflammation & Immunology Research Unit Pfizer
See the full agenda and facilitator line-up Download the strategy meeting brochure for full details

Who Should Attend the Event?

Chief Scientific Officer

Vice President, Head Research Pharmacokinetics

Global Head, Modeling and Simulation

Vice President of Biology

Head of Discovery Chemistry, Screening Biology & Operations

Head of Discovery Biology

Head of Structural Biology & Biophysics

Head of Target Science, Target & Translational Science

Head of Protein & Structural Sciences

Head of Pharmacology

Discovery DMPK & ADME

Drug Metabolism & Pharmacokinetics

See Which Topics Are Discussed at the Strategy Meeting

Why should you attend this meeting?

Understanding recent advances and alternatives for drug discovery stages discovery, development and preclinical stages that could lead to cost cutting, efficiency and early detection

Leveraging multi-omics analysis data, its advantages and limitations to further the possibilities for drug discovery applications

Exploring the discrepancy in drug metabolism between different genders and ethnic diversification that could lead to understanding the pharmacokinetics distinction between genders and ethnicity

Collaborative approaches and networking opportunities with different top-tier industry solution providers

image_one image_two image_three

Press play to hear what your colleagues had to say…

Become an official strategy meeting partner Whatever your business needs, we can help. Get in touch for partnering opportunities

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team?rnrnJust get in touch and a member of the team will be happy to help.

    I agree to Proventa International storing this information to reply to my query and in accordance with our Privacy Policy.
    You may unsubscribe at any time.
    Quick Links

    Want to find out more?

    Find out more details about our Strategy Meetings and other news and events.